Health & Medical

Roundup: Apollo Hospitals reveal use of newest RAS system, Fujitsu appoints new well being enterprise heads in ANZ, and extra briefs

Apollo Hospitals demonstrates use of Medtronic’s RAS system in surgical procedure

Apollo Hospitals, one of many greatest hospital chains in India, and Irish medical gadget maker Medtronic has partnered to reveal the primary use case of the latter’s robotics-assisted surgical procedure system in Asia-Pacific.

Medtronic’s Hugo RAS system is a modular, multi-quadrant platform for soft-tissue procedures. It options wristed devices, 3D visualisation and a cloud-based surgical video seize and administration resolution known as Touch Surgery Enterprise, mixed with devoted assist groups specialising in robotics programme optimisation, service and coaching.

RAS, a type of minimally invasive surgical procedure, can probably contribute to lowering affected person’s hospital keep, minimising surgical procedure problems and scars. 

Dr N Ragavan, who lately performed a robotic prostatectomy utilizing the Medtronic gadget, famous that just about 70% of surgical procedures in India are carried out as open procedures. “We really feel assured that the Hugo RAS system will allow us to vary that statistic and produce the advantages of minimally invasive surgical procedure to extra sufferers than ever earlier than,” the advisor urologist, uro-oncologist and robotic surgeon at Apollo Hospitals added.

“The addition of the Hugo RAS system to our robotic surgical procedure program — and our place in historical past as the primary hospital in Asia-Pacific to make use of this new expertise — reinforces that dedication and the pleasure we at Apollo Hospitals have as a premier vacation spot for minimally invasive surgical procedure. This expertise will complement the superb medical experience garnered by our physicians through the years and is designed to assist us improve affected person care,” mentioned Dr Prathap C. Reddy, founder and chairman of Apollo Hospitals Group. 

The Hugo RAS system, first utilized in urologic and gynecologic procedures in Latin America early within the yr, has pending CE mark approval in Europe; it has been designated within the US as a not-for-sale investigational gadget.

Fujitsu declares new healthcare business appointments in Australia and New Zealand

Japanese ICT service supplier Fujitsu has made new appointments in its healthcare enterprise in Australia and New Zealand.

According to a press assertion, the corporate has appointed Ian Manovel as head of Health Industry and Anthony Wang as director of Digital Transformation in Health.

“These strategic appointments reveal Fujitsu’s dedication to driving optimistic transformative change in a sector that’s beneath unprecedented strain,” mentioned Graeme Beardsell, CEO of Fujitsu Australia and New Zealand. 

Manovel will lead Fujitsu’s growth within the area’s well being sector by dealing with technique, transformation agenda, gross sales development and customer support administration. He has three a long time of expertise within the sector, together with 12 years as a pharmacist in Australia and the UK. Most lately, he labored as a authorities and healthcare consulting accomplice for DXC Technology. He had additionally been employed by Accenture, NPS MedicineWise and Bupa.

Commenting on his new function, Manovel mentioned: “I’m targeted on discovering new methods to drive healthcare innovation utilizing digital applied sciences to attain the very best well being outcomes. I look ahead to working with Fujitsu’s clients on purposeful innovation and transformation that can assist to form the way forward for healthcare supply throughout Australia and New Zealand.”

Meanwhile, Wang is bringing over twenty years of expertise in enterprise IT technique growth and supply. Previously, he was chief expertise officer at Ramsay Health Care the place he led large-scale digital initiatives, together with the primary doctor-based cell utility to entry the federal government’s My Health Record and the primary digital affected person stream program in Australian personal hospitals. He had held roles at AMP Financial Services, Optus and Accenture.

Together with Fujitsu, Wang intends to deal with the perceived challenges of remodeling the well being sector right into a patient-centric, technology-enabled house. “I’m trying ahead to harvesting the ability of AI, machine studying, quantum computing, analytics, and internet-of-medical-things to unravel these challenges presently within the too-hard basket,” he mentioned.

More pathology labs hook up with My Health Record

Pathology labs in Queensland, northern New South Wales and Tasmania have began importing affected person experiences to the federal government’s My Health Record system.

The Australian Digital Health Agency mentioned QML Pathology, IQ Pathology and TML Pathology are actually sharing experiences with customers and healthcare suppliers within the digital well being document platform.

More than 500 QML assortment centres in Queensland and northern NSW and 22 TML assortment centres in Tasmania are sending experiences to My Health Record, in response to QML Pathology General Manager Kerri McPhie. 

These connections observe the latest supply of experiences from Laverty Pathology, a subsidiary of Healius Pathology, to the federal government platform.

As of late, pathology labs throughout Australia are remitting over 1.6 million experiences every week to My Health Record.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button